Allotex's Unattributed Round

Allotex raised a round of funding on February 28, 2018.

Allotex is developing the TransForm Corneal Allograft (TCA) for the treatment of presbyopia. The TCA is created using natural human corneal tissue which has been shaped using high precision patented a…

Articles about Allotex's Unattributed Round: